Weightlossstock

TEVA Monthly: Buy Zone to Long‑Term Channel Highs Teva (TEVA) has turned a multi‑year bottom into a clean monthly up‑channel, and I’m using this pullback into support as my buy zone after the breakout. The idea is to accumulate inside this range and then ride a potential GLP‑1‑driven rerun toward the upper channel and old price memory higher up, with invalidation only on a monthly close back below the base and my stop area. If you’d like to study the methodology behind this idea, you can read more about my process and background in the profile bio.

by ConnectmyCurrency

AstraZeneca BUY: GLP‑1 Buy Zones Aiming for New Highs AstraZeneca (AZN) is grinding higher inside a weekly up‑channel, and I’m treating this current pullback toward support as a buy zone in front of a growing GLP‑1 and obesity‑drug pipeline (oral elecoglipron plus new CSPC and SixPeaks deals). My plan is to build longs in this area and target a continuation toward fresh highs and the upper channel / fib extension levels, with invalidation on a weekly close back below the channel floor and my stop zone. If you’d like to learn more about how I trade setups like this, you can find more details about me and my work in my profile bio.

by ConnectmyCurrency

GPCR 1D: GLP‑1 Buy Zone Back Toward Post‑Data Highs Structure Therapeutics (GPCR) has unwound sharply after its explosive run on positive aleniglipron obesity‑pill data, and price is now sitting in my daily buying scope inside the broader up‑channel. I’m looking for the GLP‑1 narrative and upcoming Phase 3 pivot to support a swing back toward the 85–95 area, where I’ve mapped successive upside targets aligned with prior supply and fib levels, with invalidation on a clean daily close below my lowest buy zone. If you’d like to learn more about how I trade setups like this, you can find more details about me and my work in my profile bio.

by ConnectmyCurrency

VKTX 1D: GLP‑1 Buy Zone Toward Upper‑Channel Targets Viking Therapeutics (VKTX) is pulling back into my marked daily buy zone inside the broader up‑channel, where I’m looking to load for a potential next leg higher toward the 41–46 area and the upper channel / fib targets. As long as price holds above this support band and the recent lows, I’ll treat dips as opportunities to position with the GLP‑1 obesity‑drug trend, stepping aside if we get a clean daily close back below my stop zone. If you’d like to learn more about how I trade setups like this, you can find more details about me and my work in my profile bio.

by ConnectmyCurrency